Search research articles
Contact Us
Filters
Showing results (331-340 of 362) with videos related to
Page
of 37
Sort By:
Circulation
|
June 6, 2024
Effect of Sacubitril/Valsartan on Cognitive Function in Patients With Heart Failure With Preserved Ejection Fraction: A Prespecified Analysis of PARAGON-HF
Pooja Dewan, Li Shen, João Pedro Ferreira, et al.
European Journal of Heart Failure
|
April 13, 2021
Prospective ARNI vs. ACE inhibitor trial to DetermIne Superiority in reducing heart failure Events after Myocardial Infarction (PARADISE-MI): design and baseline characteristics
Karola S Jering, Brian Claggett, Marc A Pfeffer, et al.
Circulation
|
November 2, 2022
The Effects of Angiotensin Receptor-Neprilysin Inhibition on Major Coronary Events in Patients With Acute Myocardial Infarction: Insights From the PARADISE-MI Trial
Roxana Mehran, Philippe Gabriel Steg, Marc A Pfeffer, et al.
European Journal of Heart Failure
|
May 4, 2022
Improved survival of left ventricular assist device carriers in Europe according to implantation eras: results from the PCHF-VAD registry
Nina Jakus, Jasper J Brugts, Brian Claggett, et al.
Nature Medicine
|
March 18, 2023
Author Correction: Dapagliflozin in heart failure with improved ejection fraction: a prespecified analysis of the DELIVER trial
Orly Vardeny, James C Fang, Akshay S Desai, et al.
Circulation
|
October 21, 2024
Clinical Correlates and Prognostic Impact of Cognitive Dysfunction in Patients With Heart Failure and Preserved Ejection Fraction: Insights From PARAGON-HF
Li Shen, Pooja Dewan, João Pedro Ferreira, et al.
Nature Medicine
|
December 15, 2022
Dapagliflozin in heart failure with improved ejection fraction: a prespecified analysis of the DELIVER trial
Orly Vardeny, James C Fang, Akshay S Desai, et al.
European Journal of Heart Failure
|
April 16, 2026
Hemodynamic Changes in Response to GLP-1 Treatment in ICD and CRT Patients: Insights From HeartLogic Sensor Data
Frederik Holme Fussing, Lise Witten Davodian, Danny Witten Davodian, et al.
Circulation. Heart Failure
|
August 1, 2024
Quality of Life and Exercise Capacity in Early Stage and Subclinical Hypertrophic Cardiomyopathy: A Secondary Analysis of the VANISH Trial
Catherine G Ireland, Danielle S Burstein, Sharlene M Day, et al.
European Heart Journal
|
August 27, 2022
Dapagliflozin for heart failure according to body mass index: the DELIVER trial
Carly Adamson, Toru Kondo, Pardeep S Jhund, et al.
Page
of 37
Search research articles
Search
Showing results (331-340 of 362) with videos related to
Sort By:
Page
of 37
Circulation
|
June 6, 2024
Effect of Sacubitril/Valsartan on Cognitive Function in Patients With Heart Failure With Preserved Ejection Fraction: A Prespecified Analysis of PARAGON-HF
Pooja Dewan, Li Shen, João Pedro Ferreira, et al.
European Journal of Heart Failure
|
April 13, 2021
Prospective ARNI vs. ACE inhibitor trial to DetermIne Superiority in reducing heart failure Events after Myocardial Infarction (PARADISE-MI): design and baseline characteristics
Karola S Jering, Brian Claggett, Marc A Pfeffer, et al.
Circulation
|
November 2, 2022
The Effects of Angiotensin Receptor-Neprilysin Inhibition on Major Coronary Events in Patients With Acute Myocardial Infarction: Insights From the PARADISE-MI Trial
Roxana Mehran, Philippe Gabriel Steg, Marc A Pfeffer, et al.
European Journal of Heart Failure
|
May 4, 2022
Improved survival of left ventricular assist device carriers in Europe according to implantation eras: results from the PCHF-VAD registry
Nina Jakus, Jasper J Brugts, Brian Claggett, et al.
Nature Medicine
|
March 18, 2023
Author Correction: Dapagliflozin in heart failure with improved ejection fraction: a prespecified analysis of the DELIVER trial
Orly Vardeny, James C Fang, Akshay S Desai, et al.
Circulation
|
October 21, 2024
Clinical Correlates and Prognostic Impact of Cognitive Dysfunction in Patients With Heart Failure and Preserved Ejection Fraction: Insights From PARAGON-HF
Li Shen, Pooja Dewan, João Pedro Ferreira, et al.
Nature Medicine
|
December 15, 2022
Dapagliflozin in heart failure with improved ejection fraction: a prespecified analysis of the DELIVER trial
Orly Vardeny, James C Fang, Akshay S Desai, et al.
European Journal of Heart Failure
|
April 16, 2026
Hemodynamic Changes in Response to GLP-1 Treatment in ICD and CRT Patients: Insights From HeartLogic Sensor Data
Frederik Holme Fussing, Lise Witten Davodian, Danny Witten Davodian, et al.
Circulation. Heart Failure
|
August 1, 2024
Quality of Life and Exercise Capacity in Early Stage and Subclinical Hypertrophic Cardiomyopathy: A Secondary Analysis of the VANISH Trial
Catherine G Ireland, Danielle S Burstein, Sharlene M Day, et al.
European Heart Journal
|
August 27, 2022
Dapagliflozin for heart failure according to body mass index: the DELIVER trial
Carly Adamson, Toru Kondo, Pardeep S Jhund, et al.
Page
of 37